Fleury Surges 50% YTD, BTG Attributes Rally to Fundamentals

Fleury's stock has risen nearly 50% year-to-date, triple the Ibovespa's gain and outperforming healthcare peers. BTG Pactual attributes the rally to two factors, likely improved earnings and strategic positioning, though specifics are pending. The move signals investor confidence in the company's growth trajectory.